Nerfasin 20: quality issue (presence of particles)
Last updated
Summary
Product
Nerfasin 20
Issue
Health products - Product quality
What to do
See instructions below.
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot |
|---|---|---|---|---|---|
Nerfasin 20 |
Nerfasin 20 |
DIN 02444089 |
Solution (for injection) |
Xylazine (Xylazine Hydrochloride) 20mg/ml |
19J038 |
Issue
| Affected lot may contain the presence of particles |
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Wholesalers, Veterinary Clinics.
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Veterinary drugs
Companies
Dechra Veterinary Products Inc.
1 Holiday Ave, East Tower, Suite 345
Pointe-Claire, Quebec,
H9R 5N3
Published by
Health Canada
Audience
General public
Health professionals
Hospitals
Recall class
Type I
Identification number
RA-63664
Get notified
Receive notifications for new and updated recalls and alerts by category.